Chargement en cours...
Gambogic acid potentiates gemcitabine induced anticancer activity in non-small cell lung cancer
Non-small cell lung cancer (NSCLC) is the most frequent type of lung cancer accounting up to 80-85% of all lung cancer cases. Gemcitabine (Gem), a pyrimidine nucleoside antimetabolite, is widely used chemotherapy offering several months survival benefit in patients with NSCLC. The emergence of Gem r...
Enregistré dans:
| Publié dans: | Eur J Pharmacol |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7669739/ https://ncbi.nlm.nih.gov/pubmed/32805254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejphar.2020.173486 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|